Both in Pharmaceuticals
uniQure vs Innoviva
Over the past year QURE returned −31.7% and INVA returned +16.5%; their daily moves had a correlation of 0.16.
QURE −31.7% INVA +16.5%Growth of $1, one year, split-adjusted
| Metric | QURE | INVA |
|---|---|---|
| Price | $23.44 | $21.09 |
| Market cap | $1.63B | $1.52B |
| Today | +2.02% | +0.33% |
| 1 month | +2.8% | +2.2% |
| 6 months | +10.8% | −6.9% |
| Year to date | −2.1% | +5.5% |
| 1 year | −65.4% | +15.9% |
| Revenue growth (YoY) | +11.0% | +19.3% |
| Gross margin | 94.0% | 81.3% |
| Net margin | −1387.8% | −69.8% |
| P/E (TTM) | — | 4.3× |
| Price / sales | 87.1× | 3.5× |
| Net cash | $760.2M | $319.0M |
| Dividend yield | — | — |
| Volatility (60d) | 108.8% | 20.9% |
| Short % of float | 13.2% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).